v3.26.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2025
Dec. 31, 2024
Current Assets:    
Cash $ 101,778 $ 1,530,924
Prepaid expenses and other current assets 231,639 184,873
Vendor deposits 14,484
Total Current Assets 347,901 1,715,797
In-process research and development 18,647,903
Vendor deposit 178,476
Deferred offering costs 57,238
Total Assets 347,901 20,599,414
Current Liabilities:    
Accounts payable 10,123,391 9,337,267
Accrued expenses and other current liabilities 2,611,296 1,894,041
Total Current Liabilities 12,734,687 11,231,308
Deferred tax liability 851,659
Total Liabilities 12,734,687 12,082,967
Commitments and contingencies (Note 6)
Stockholders’ (Deficit) Equity:    
Common stock 809 251
Additional paid-in-capital 125,204,509 121,155,922
Accumulated deficit (137,584,937) (112,632,559)
Treasury stock, at cost, 7 shares at December 31, 2025 and 2024 (7,168) (7,168)
Total Stockholders’ (Deficit) Equity (12,386,786) 8,516,447
Total Liabilities and Stockholders’ (Deficit) Equity 347,901 20,599,414
Series A Preferred Stock [Member]    
Stockholders’ (Deficit) Equity:    
Preferred stock
Series B Preferred Stock [Member]    
Stockholders’ (Deficit) Equity:    
Preferred stock $ 1 $ 1